Patrick Morgante, DO
Family Medicine · Havelock, NCNPI 1881655371
Payments from drug & device makers
Across 120 payments — averaging $38,555 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$2.2M
- Modernatx, Inc.$1.3M
- Amgen$544K
- Eli Lilly$508K
- E.r. Squibb & Sons, L.L.C.$65K
- Cleerly, Inc.$25K
- plus $111 from 2 others
Across 3 payments — averaging $135,899 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$408K
What the payments were for
- Travel & lodging$1,78373%
- Food & beverage$65127%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 4 | $2,173,832 |
| Modernatx, Inc. | 92 | $1,311,039 |
| Amgen | 7 | $543,742 |
| Eli Lilly | 2 | $507,779 |
| E.r. Squibb & Sons, L.L.C. | 4 | $65,107 |
| Cleerly, Inc. | 8 | $24,992 |
| Organon | 2 | $69 |
| Boston Scientific | 1 | $42 |
How this compares
$4,626,601 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 52 | $62,279 |
| OzempicSemaglutide | 33 | $47,475 |
| EliquisApixaban | 35 | $43,361 |
| JardianceEmpagliflozin | 18 | $19,383 |
| JanuviaSitagliptin Phosphate | 13 | $16,596 |
| XareltoRivaroxaban | 12 | $14,164 |
| TrulicityDulaglutide | 12 | $12,967 |
| LinzessLinaclotide | 20 | $11,609 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $6,478 |
| Rosuvastatin Calcium | 266 | $3,660 |
| Atorvastatin Calcium | 185 | $2,156 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,898 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,837 |
| Levothyroxine Sodium | 123 | $1,725 |
| Telmisartan | 30 | $1,363 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Havelock
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Stephen JonesShelby$4.5M
- Steven BauerCharlotte$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.